nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Cytochrome P450 2C8 Inhibitors—Pazopanib—kidney cancer	0.398	0.644	CiPCiCtD
Atazanavir—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.11	0.178	CiPCiCtD
Atazanavir—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.11	0.178	CiPCiCtD
Atazanavir—ABCB1—kidney cancer	0.0815	1	CbGaD
Atazanavir—SLCO1B3—Paclitaxel—kidney cancer	0.0261	0.118	CbGbCtD
Atazanavir—ABCC1—Dactinomycin—kidney cancer	0.0252	0.114	CbGbCtD
Atazanavir—ABCC1—Paclitaxel—kidney cancer	0.018	0.0817	CbGbCtD
Atazanavir—ABCC1—Vinblastine—kidney cancer	0.0158	0.0716	CbGbCtD
Atazanavir—ABCC1—Vincristine—kidney cancer	0.0155	0.0704	CbGbCtD
Atazanavir—ABCB1—Temsirolimus—kidney cancer	0.0127	0.0574	CbGbCtD
Atazanavir—CYP3A4—Everolimus—kidney cancer	0.0112	0.0509	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—kidney cancer	0.00971	0.044	CbGbCtD
Atazanavir—CYP3A4—Temsirolimus—kidney cancer	0.00759	0.0344	CbGbCtD
Atazanavir—CYP2C9—Capecitabine—kidney cancer	0.00715	0.0324	CbGbCtD
Atazanavir—ABCB1—Pazopanib—kidney cancer	0.00666	0.0302	CbGbCtD
Atazanavir—ABCB1—Dactinomycin—kidney cancer	0.00609	0.0276	CbGbCtD
Atazanavir—ABCB1—Gemcitabine—kidney cancer	0.00481	0.0218	CbGbCtD
Atazanavir—ABCB1—Erlotinib—kidney cancer	0.00475	0.0215	CbGbCtD
Atazanavir—CYP2C9—Paclitaxel—kidney cancer	0.00448	0.0203	CbGbCtD
Atazanavir—ABCB1—Paclitaxel—kidney cancer	0.00435	0.0197	CbGbCtD
Atazanavir—CYP3A4—Pazopanib—kidney cancer	0.00399	0.0181	CbGbCtD
Atazanavir—CYP2C9—Sorafenib—kidney cancer	0.00398	0.018	CbGbCtD
Atazanavir—ABCB1—Sorafenib—kidney cancer	0.00386	0.0175	CbGbCtD
Atazanavir—ABCB1—Vinblastine—kidney cancer	0.00381	0.0173	CbGbCtD
Atazanavir—ABCB1—Vincristine—kidney cancer	0.00375	0.017	CbGbCtD
Atazanavir—ABCB1—Sunitinib—kidney cancer	0.00313	0.0142	CbGbCtD
Atazanavir—CYP3A4—Erlotinib—kidney cancer	0.00285	0.0129	CbGbCtD
Atazanavir—CYP3A4—Paclitaxel—kidney cancer	0.00261	0.0118	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—kidney cancer	0.00234	0.0106	CbGbCtD
Atazanavir—CYP3A4—Sorafenib—kidney cancer	0.00231	0.0105	CbGbCtD
Atazanavir—CYP3A4—Vinblastine—kidney cancer	0.00228	0.0104	CbGbCtD
Atazanavir—CYP3A4—Vincristine—kidney cancer	0.00225	0.0102	CbGbCtD
Atazanavir—CYP3A4—Sunitinib—kidney cancer	0.00187	0.0085	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—kidney cancer	0.0014	0.00636	CbGbCtD
Atazanavir—Lopinavir—ABCB1—kidney cancer	0.00015	0.404	CrCbGaD
Atazanavir—Ritonavir—ABCB1—kidney cancer	0.000126	0.339	CrCbGaD
Atazanavir—Saquinavir—ABCB1—kidney cancer	9.56e-05	0.257	CrCbGaD
Atazanavir—Asthenia—Sunitinib—kidney cancer	3e-05	0.000381	CcSEcCtD
Atazanavir—Dyspnoea—Gemcitabine—kidney cancer	2.99e-05	0.00038	CcSEcCtD
Atazanavir—Nausea—Vinblastine—kidney cancer	2.99e-05	0.00038	CcSEcCtD
Atazanavir—Somnolence—Gemcitabine—kidney cancer	2.99e-05	0.000379	CcSEcCtD
Atazanavir—Convulsion—Paclitaxel—kidney cancer	2.99e-05	0.000379	CcSEcCtD
Atazanavir—Affect lability—Doxorubicin—kidney cancer	2.98e-05	0.000378	CcSEcCtD
Atazanavir—Nausea—Everolimus—kidney cancer	2.98e-05	0.000378	CcSEcCtD
Atazanavir—Diarrhoea—Sorafenib—kidney cancer	2.98e-05	0.000378	CcSEcCtD
Atazanavir—Hypertension—Paclitaxel—kidney cancer	2.97e-05	0.000378	CcSEcCtD
Atazanavir—Pruritus—Sunitinib—kidney cancer	2.96e-05	0.000376	CcSEcCtD
Atazanavir—Angiopathy—Capecitabine—kidney cancer	2.95e-05	0.000374	CcSEcCtD
Atazanavir—Immune system disorder—Capecitabine—kidney cancer	2.93e-05	0.000373	CcSEcCtD
Atazanavir—Arthralgia—Paclitaxel—kidney cancer	2.93e-05	0.000373	CcSEcCtD
Atazanavir—Chest pain—Paclitaxel—kidney cancer	2.93e-05	0.000373	CcSEcCtD
Atazanavir—Myalgia—Paclitaxel—kidney cancer	2.93e-05	0.000373	CcSEcCtD
Atazanavir—Mediastinal disorder—Capecitabine—kidney cancer	2.93e-05	0.000372	CcSEcCtD
Atazanavir—Anxiety—Paclitaxel—kidney cancer	2.92e-05	0.000371	CcSEcCtD
Atazanavir—Decreased appetite—Gemcitabine—kidney cancer	2.92e-05	0.000371	CcSEcCtD
Atazanavir—Hypersensitivity—Dactinomycin—kidney cancer	2.92e-05	0.000371	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.91e-05	0.00037	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.9e-05	0.000368	CcSEcCtD
Atazanavir—Discomfort—Paclitaxel—kidney cancer	2.9e-05	0.000368	CcSEcCtD
Atazanavir—Fatigue—Gemcitabine—kidney cancer	2.9e-05	0.000368	CcSEcCtD
Atazanavir—Gastrointestinal pain—Vincristine—kidney cancer	2.89e-05	0.000368	CcSEcCtD
Atazanavir—Cardiac arrest—Doxorubicin—kidney cancer	2.88e-05	0.000366	CcSEcCtD
Atazanavir—Dizziness—Sorafenib—kidney cancer	2.88e-05	0.000365	CcSEcCtD
Atazanavir—Constipation—Gemcitabine—kidney cancer	2.87e-05	0.000365	CcSEcCtD
Atazanavir—Pain—Gemcitabine—kidney cancer	2.87e-05	0.000365	CcSEcCtD
Atazanavir—Nausea—Erlotinib—kidney cancer	2.87e-05	0.000365	CcSEcCtD
Atazanavir—Alopecia—Capecitabine—kidney cancer	2.87e-05	0.000365	CcSEcCtD
Atazanavir—Dry mouth—Paclitaxel—kidney cancer	2.87e-05	0.000364	CcSEcCtD
Atazanavir—Mood swings—Doxorubicin—kidney cancer	2.87e-05	0.000364	CcSEcCtD
Atazanavir—Diarrhoea—Sunitinib—kidney cancer	2.86e-05	0.000364	CcSEcCtD
Atazanavir—Mental disorder—Capecitabine—kidney cancer	2.85e-05	0.000361	CcSEcCtD
Atazanavir—Asthenia—Dactinomycin—kidney cancer	2.84e-05	0.000361	CcSEcCtD
Atazanavir—Confusional state—Paclitaxel—kidney cancer	2.84e-05	0.00036	CcSEcCtD
Atazanavir—Malnutrition—Capecitabine—kidney cancer	2.83e-05	0.000359	CcSEcCtD
Atazanavir—Dehydration—Doxorubicin—kidney cancer	2.81e-05	0.000357	CcSEcCtD
Atazanavir—Oedema—Paclitaxel—kidney cancer	2.81e-05	0.000357	CcSEcCtD
Atazanavir—Abdominal pain—Vincristine—kidney cancer	2.8e-05	0.000355	CcSEcCtD
Atazanavir—Body temperature increased—Vincristine—kidney cancer	2.8e-05	0.000355	CcSEcCtD
Atazanavir—Infection—Paclitaxel—kidney cancer	2.79e-05	0.000355	CcSEcCtD
Atazanavir—Flatulence—Capecitabine—kidney cancer	2.79e-05	0.000354	CcSEcCtD
Atazanavir—Dry skin—Doxorubicin—kidney cancer	2.77e-05	0.000352	CcSEcCtD
Atazanavir—Dysgeusia—Capecitabine—kidney cancer	2.77e-05	0.000352	CcSEcCtD
Atazanavir—Dizziness—Sunitinib—kidney cancer	2.77e-05	0.000352	CcSEcCtD
Atazanavir—Feeling abnormal—Gemcitabine—kidney cancer	2.77e-05	0.000352	CcSEcCtD
Atazanavir—Shock—Paclitaxel—kidney cancer	2.77e-05	0.000351	CcSEcCtD
Atazanavir—Vomiting—Sorafenib—kidney cancer	2.77e-05	0.000351	CcSEcCtD
Atazanavir—Nervous system disorder—Paclitaxel—kidney cancer	2.76e-05	0.00035	CcSEcCtD
Atazanavir—Rash—Sorafenib—kidney cancer	2.74e-05	0.000348	CcSEcCtD
Atazanavir—Dermatitis—Sorafenib—kidney cancer	2.74e-05	0.000348	CcSEcCtD
Atazanavir—Back pain—Capecitabine—kidney cancer	2.73e-05	0.000347	CcSEcCtD
Atazanavir—Breast disorder—Doxorubicin—kidney cancer	2.73e-05	0.000347	CcSEcCtD
Atazanavir—Skin disorder—Paclitaxel—kidney cancer	2.73e-05	0.000347	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.73e-05	0.000346	CcSEcCtD
Atazanavir—Headache—Sorafenib—kidney cancer	2.72e-05	0.000346	CcSEcCtD
Atazanavir—Hyperhidrosis—Paclitaxel—kidney cancer	2.72e-05	0.000345	CcSEcCtD
Atazanavir—Diarrhoea—Dactinomycin—kidney cancer	2.71e-05	0.000344	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—kidney cancer	2.71e-05	0.000344	CcSEcCtD
Atazanavir—Anorexia—Paclitaxel—kidney cancer	2.68e-05	0.00034	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—kidney cancer	2.68e-05	0.00034	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—kidney cancer	2.67e-05	0.000339	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—kidney cancer	2.67e-05	0.000339	CcSEcCtD
Atazanavir—Vomiting—Sunitinib—kidney cancer	2.66e-05	0.000338	CcSEcCtD
Atazanavir—Body temperature increased—Gemcitabine—kidney cancer	2.65e-05	0.000337	CcSEcCtD
Atazanavir—Rash—Sunitinib—kidney cancer	2.64e-05	0.000335	CcSEcCtD
Atazanavir—Dermatitis—Sunitinib—kidney cancer	2.64e-05	0.000335	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—kidney cancer	2.63e-05	0.000334	CcSEcCtD
Atazanavir—Ill-defined disorder—Capecitabine—kidney cancer	2.62e-05	0.000333	CcSEcCtD
Atazanavir—Headache—Sunitinib—kidney cancer	2.62e-05	0.000333	CcSEcCtD
Atazanavir—Hypersensitivity—Vincristine—kidney cancer	2.61e-05	0.000331	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—kidney cancer	2.59e-05	0.000329	CcSEcCtD
Atazanavir—Nausea—Sorafenib—kidney cancer	2.58e-05	0.000328	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—kidney cancer	2.56e-05	0.000326	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.56e-05	0.000325	CcSEcCtD
Atazanavir—Malaise—Capecitabine—kidney cancer	2.55e-05	0.000324	CcSEcCtD
Atazanavir—Insomnia—Paclitaxel—kidney cancer	2.54e-05	0.000323	CcSEcCtD
Atazanavir—Asthenia—Vincristine—kidney cancer	2.54e-05	0.000323	CcSEcCtD
Atazanavir—Syncope—Capecitabine—kidney cancer	2.54e-05	0.000322	CcSEcCtD
Atazanavir—Vomiting—Dactinomycin—kidney cancer	2.52e-05	0.00032	CcSEcCtD
Atazanavir—Dyspnoea—Paclitaxel—kidney cancer	2.51e-05	0.000318	CcSEcCtD
Atazanavir—Somnolence—Paclitaxel—kidney cancer	2.5e-05	0.000318	CcSEcCtD
Atazanavir—Palpitations—Capecitabine—kidney cancer	2.5e-05	0.000317	CcSEcCtD
Atazanavir—Rash—Dactinomycin—kidney cancer	2.5e-05	0.000317	CcSEcCtD
Atazanavir—Nausea—Sunitinib—kidney cancer	2.49e-05	0.000316	CcSEcCtD
Atazanavir—Loss of consciousness—Capecitabine—kidney cancer	2.49e-05	0.000316	CcSEcCtD
Atazanavir—Dyspepsia—Paclitaxel—kidney cancer	2.48e-05	0.000314	CcSEcCtD
Atazanavir—Cough—Capecitabine—kidney cancer	2.47e-05	0.000313	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—kidney cancer	2.45e-05	0.000311	CcSEcCtD
Atazanavir—Decreased appetite—Paclitaxel—kidney cancer	2.44e-05	0.00031	CcSEcCtD
Atazanavir—Hypertension—Capecitabine—kidney cancer	2.44e-05	0.00031	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.43e-05	0.000308	CcSEcCtD
Atazanavir—Fatigue—Paclitaxel—kidney cancer	2.42e-05	0.000308	CcSEcCtD
Atazanavir—Diarrhoea—Vincristine—kidney cancer	2.42e-05	0.000308	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—kidney cancer	2.42e-05	0.000307	CcSEcCtD
Atazanavir—Asthenia—Gemcitabine—kidney cancer	2.41e-05	0.000306	CcSEcCtD
Atazanavir—Myalgia—Capecitabine—kidney cancer	2.41e-05	0.000306	CcSEcCtD
Atazanavir—Chest pain—Capecitabine—kidney cancer	2.41e-05	0.000306	CcSEcCtD
Atazanavir—Arthralgia—Capecitabine—kidney cancer	2.41e-05	0.000306	CcSEcCtD
Atazanavir—Constipation—Paclitaxel—kidney cancer	2.4e-05	0.000305	CcSEcCtD
Atazanavir—Pain—Paclitaxel—kidney cancer	2.4e-05	0.000305	CcSEcCtD
Atazanavir—Anxiety—Capecitabine—kidney cancer	2.4e-05	0.000305	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.39e-05	0.000304	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—kidney cancer	2.39e-05	0.000303	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—kidney cancer	2.38e-05	0.000302	CcSEcCtD
Atazanavir—Discomfort—Capecitabine—kidney cancer	2.38e-05	0.000302	CcSEcCtD
Atazanavir—Pruritus—Gemcitabine—kidney cancer	2.38e-05	0.000302	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—kidney cancer	2.37e-05	0.000301	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—kidney cancer	2.36e-05	0.0003	CcSEcCtD
Atazanavir—Dry mouth—Capecitabine—kidney cancer	2.35e-05	0.000299	CcSEcCtD
Atazanavir—Nausea—Dactinomycin—kidney cancer	2.35e-05	0.000299	CcSEcCtD
Atazanavir—Dizziness—Vincristine—kidney cancer	2.34e-05	0.000297	CcSEcCtD
Atazanavir—Confusional state—Capecitabine—kidney cancer	2.33e-05	0.000296	CcSEcCtD
Atazanavir—Feeling abnormal—Paclitaxel—kidney cancer	2.32e-05	0.000294	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.31e-05	0.000294	CcSEcCtD
Atazanavir—Oedema—Capecitabine—kidney cancer	2.31e-05	0.000293	CcSEcCtD
Atazanavir—Gastrointestinal pain—Paclitaxel—kidney cancer	2.3e-05	0.000292	CcSEcCtD
Atazanavir—Diarrhoea—Gemcitabine—kidney cancer	2.3e-05	0.000292	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—kidney cancer	2.29e-05	0.000291	CcSEcCtD
Atazanavir—Infection—Capecitabine—kidney cancer	2.29e-05	0.000291	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—kidney cancer	2.29e-05	0.00029	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—kidney cancer	2.27e-05	0.000289	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—kidney cancer	2.27e-05	0.000289	CcSEcCtD
Atazanavir—Shock—Capecitabine—kidney cancer	2.27e-05	0.000288	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—kidney cancer	2.27e-05	0.000288	CcSEcCtD
Atazanavir—Nervous system disorder—Capecitabine—kidney cancer	2.26e-05	0.000287	CcSEcCtD
Atazanavir—Vomiting—Vincristine—kidney cancer	2.25e-05	0.000286	CcSEcCtD
Atazanavir—Skin disorder—Capecitabine—kidney cancer	2.24e-05	0.000285	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—kidney cancer	2.24e-05	0.000284	CcSEcCtD
Atazanavir—Urticaria—Paclitaxel—kidney cancer	2.23e-05	0.000284	CcSEcCtD
Atazanavir—Rash—Vincristine—kidney cancer	2.23e-05	0.000284	CcSEcCtD
Atazanavir—Hyperhidrosis—Capecitabine—kidney cancer	2.23e-05	0.000283	CcSEcCtD
Atazanavir—Dermatitis—Vincristine—kidney cancer	2.23e-05	0.000283	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—kidney cancer	2.22e-05	0.000282	CcSEcCtD
Atazanavir—Body temperature increased—Paclitaxel—kidney cancer	2.22e-05	0.000282	CcSEcCtD
Atazanavir—Abdominal pain—Paclitaxel—kidney cancer	2.22e-05	0.000282	CcSEcCtD
Atazanavir—Headache—Vincristine—kidney cancer	2.22e-05	0.000282	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—kidney cancer	2.21e-05	0.00028	CcSEcCtD
Atazanavir—Anorexia—Capecitabine—kidney cancer	2.2e-05	0.000279	CcSEcCtD
Atazanavir—Vomiting—Gemcitabine—kidney cancer	2.14e-05	0.000271	CcSEcCtD
Atazanavir—Rash—Gemcitabine—kidney cancer	2.12e-05	0.000269	CcSEcCtD
Atazanavir—Dermatitis—Gemcitabine—kidney cancer	2.12e-05	0.000269	CcSEcCtD
Atazanavir—Headache—Gemcitabine—kidney cancer	2.1e-05	0.000267	CcSEcCtD
Atazanavir—Nausea—Vincristine—kidney cancer	2.1e-05	0.000267	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.1e-05	0.000267	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—kidney cancer	2.09e-05	0.000266	CcSEcCtD
Atazanavir—Insomnia—Capecitabine—kidney cancer	2.09e-05	0.000265	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—kidney cancer	2.08e-05	0.000265	CcSEcCtD
Atazanavir—Hypersensitivity—Paclitaxel—kidney cancer	2.07e-05	0.000263	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—kidney cancer	2.07e-05	0.000263	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—kidney cancer	2.06e-05	0.000262	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—kidney cancer	2.06e-05	0.000261	CcSEcCtD
Atazanavir—Dyspnoea—Capecitabine—kidney cancer	2.06e-05	0.000261	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—kidney cancer	2.05e-05	0.000261	CcSEcCtD
Atazanavir—Dyspepsia—Capecitabine—kidney cancer	2.03e-05	0.000258	CcSEcCtD
Atazanavir—Asthenia—Paclitaxel—kidney cancer	2.02e-05	0.000256	CcSEcCtD
Atazanavir—Decreased appetite—Capecitabine—kidney cancer	2.01e-05	0.000255	CcSEcCtD
Atazanavir—Nausea—Gemcitabine—kidney cancer	1.99e-05	0.000253	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Capecitabine—kidney cancer	1.99e-05	0.000253	CcSEcCtD
Atazanavir—Fatigue—Capecitabine—kidney cancer	1.99e-05	0.000253	CcSEcCtD
Atazanavir—Pruritus—Paclitaxel—kidney cancer	1.99e-05	0.000253	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—kidney cancer	1.98e-05	0.000251	CcSEcCtD
Atazanavir—Constipation—Capecitabine—kidney cancer	1.97e-05	0.000251	CcSEcCtD
Atazanavir—Pain—Capecitabine—kidney cancer	1.97e-05	0.000251	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—kidney cancer	1.96e-05	0.000249	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—kidney cancer	1.95e-05	0.000248	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—kidney cancer	1.94e-05	0.000247	CcSEcCtD
Atazanavir—Diarrhoea—Paclitaxel—kidney cancer	1.92e-05	0.000244	CcSEcCtD
Atazanavir—Feeling abnormal—Capecitabine—kidney cancer	1.9e-05	0.000242	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—kidney cancer	1.9e-05	0.000241	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—kidney cancer	1.89e-05	0.00024	CcSEcCtD
Atazanavir—Gastrointestinal pain—Capecitabine—kidney cancer	1.89e-05	0.00024	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—kidney cancer	1.89e-05	0.00024	CcSEcCtD
Atazanavir—Dizziness—Paclitaxel—kidney cancer	1.86e-05	0.000236	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—kidney cancer	1.85e-05	0.000235	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—kidney cancer	1.83e-05	0.000233	CcSEcCtD
Atazanavir—Urticaria—Capecitabine—kidney cancer	1.83e-05	0.000233	CcSEcCtD
Atazanavir—Abdominal pain—Capecitabine—kidney cancer	1.82e-05	0.000232	CcSEcCtD
Atazanavir—Body temperature increased—Capecitabine—kidney cancer	1.82e-05	0.000232	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—kidney cancer	1.82e-05	0.000231	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—kidney cancer	1.8e-05	0.000228	CcSEcCtD
Atazanavir—Tension—Doxorubicin—kidney cancer	1.79e-05	0.000227	CcSEcCtD
Atazanavir—Vomiting—Paclitaxel—kidney cancer	1.79e-05	0.000227	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—kidney cancer	1.78e-05	0.000227	CcSEcCtD
Atazanavir—Rash—Paclitaxel—kidney cancer	1.77e-05	0.000225	CcSEcCtD
Atazanavir—Dermatitis—Paclitaxel—kidney cancer	1.77e-05	0.000225	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—kidney cancer	1.77e-05	0.000225	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—kidney cancer	1.76e-05	0.000224	CcSEcCtD
Atazanavir—Headache—Paclitaxel—kidney cancer	1.76e-05	0.000224	CcSEcCtD
Atazanavir—Hypersensitivity—Capecitabine—kidney cancer	1.7e-05	0.000216	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—kidney cancer	1.69e-05	0.000215	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—kidney cancer	1.67e-05	0.000213	CcSEcCtD
Atazanavir—Nausea—Paclitaxel—kidney cancer	1.67e-05	0.000212	CcSEcCtD
Atazanavir—Asthenia—Capecitabine—kidney cancer	1.66e-05	0.00021	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—kidney cancer	1.64e-05	0.000209	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—kidney cancer	1.63e-05	0.000208	CcSEcCtD
Atazanavir—Pruritus—Capecitabine—kidney cancer	1.63e-05	0.000207	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—kidney cancer	1.61e-05	0.000205	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—kidney cancer	1.6e-05	0.000203	CcSEcCtD
Atazanavir—Cough—Doxorubicin—kidney cancer	1.59e-05	0.000202	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—kidney cancer	1.58e-05	0.000201	CcSEcCtD
Atazanavir—Diarrhoea—Capecitabine—kidney cancer	1.58e-05	0.000201	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—kidney cancer	1.57e-05	0.0002	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—kidney cancer	1.55e-05	0.000197	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—kidney cancer	1.55e-05	0.000197	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—kidney cancer	1.55e-05	0.000197	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—kidney cancer	1.55e-05	0.000196	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.54e-05	0.000196	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—kidney cancer	1.53e-05	0.000195	CcSEcCtD
Atazanavir—Dizziness—Capecitabine—kidney cancer	1.53e-05	0.000194	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—kidney cancer	1.52e-05	0.000193	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—kidney cancer	1.5e-05	0.000191	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—kidney cancer	1.49e-05	0.000189	CcSEcCtD
Atazanavir—Infection—Doxorubicin—kidney cancer	1.48e-05	0.000188	CcSEcCtD
Atazanavir—Vomiting—Capecitabine—kidney cancer	1.47e-05	0.000186	CcSEcCtD
Atazanavir—Shock—Doxorubicin—kidney cancer	1.46e-05	0.000186	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—kidney cancer	1.46e-05	0.000185	CcSEcCtD
Atazanavir—Rash—Capecitabine—kidney cancer	1.45e-05	0.000185	CcSEcCtD
Atazanavir—Dermatitis—Capecitabine—kidney cancer	1.45e-05	0.000185	CcSEcCtD
Atazanavir—Headache—Capecitabine—kidney cancer	1.45e-05	0.000184	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—kidney cancer	1.44e-05	0.000184	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—kidney cancer	1.44e-05	0.000183	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—kidney cancer	1.42e-05	0.00018	CcSEcCtD
Atazanavir—Nausea—Capecitabine—kidney cancer	1.37e-05	0.000174	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.36e-05	0.000172	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—kidney cancer	1.35e-05	0.000171	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—kidney cancer	1.33e-05	0.000168	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—kidney cancer	1.32e-05	0.000168	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—kidney cancer	1.31e-05	0.000166	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—kidney cancer	1.29e-05	0.000164	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.28e-05	0.000163	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—kidney cancer	1.28e-05	0.000163	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—kidney cancer	1.27e-05	0.000162	CcSEcCtD
Atazanavir—Pain—Doxorubicin—kidney cancer	1.27e-05	0.000162	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—kidney cancer	1.23e-05	0.000156	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—kidney cancer	1.22e-05	0.000154	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—kidney cancer	1.18e-05	0.00015	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—kidney cancer	1.18e-05	0.000149	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—kidney cancer	1.18e-05	0.000149	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—kidney cancer	1.1e-05	0.000139	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—kidney cancer	1.07e-05	0.000136	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—kidney cancer	1.05e-05	0.000134	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—kidney cancer	1.02e-05	0.000129	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—kidney cancer	9.84e-06	0.000125	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—kidney cancer	9.46e-06	0.00012	CcSEcCtD
Atazanavir—Rash—Doxorubicin—kidney cancer	9.38e-06	0.000119	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—kidney cancer	9.37e-06	0.000119	CcSEcCtD
Atazanavir—Headache—Doxorubicin—kidney cancer	9.32e-06	0.000118	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—kidney cancer	8.84e-06	0.000112	CcSEcCtD
Atazanavir—SLCO1B3—Metabolism—CA9—kidney cancer	3.13e-06	0.00197	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.12e-06	0.00196	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.11e-06	0.00196	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PGK1—kidney cancer	3.11e-06	0.00196	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SLC5A3—kidney cancer	3.11e-06	0.00196	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	3.09e-06	0.00195	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.06e-06	0.00193	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SFRP2—kidney cancer	3.05e-06	0.00192	CbGpPWpGaD
Atazanavir—ABCC1—Disease—LDHB—kidney cancer	3.05e-06	0.00192	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GPC3—kidney cancer	3e-06	0.00189	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.93e-06	0.00184	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CA2—kidney cancer	2.92e-06	0.00184	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GSTP1—kidney cancer	2.88e-06	0.00181	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.86e-06	0.0018	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALAD—kidney cancer	2.85e-06	0.00179	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TCEB1—kidney cancer	2.85e-06	0.00179	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TCEB2—kidney cancer	2.85e-06	0.00179	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	2.84e-06	0.00178	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.83e-06	0.00178	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ST3GAL2—kidney cancer	2.78e-06	0.00175	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	2.77e-06	0.00174	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—IL2—kidney cancer	2.76e-06	0.00173	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	2.74e-06	0.00173	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.74e-06	0.00172	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALDH1A1—kidney cancer	2.72e-06	0.00171	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	2.7e-06	0.0017	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CRABP1—kidney cancer	2.66e-06	0.00168	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.65e-06	0.00166	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.65e-06	0.00166	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.65e-06	0.00166	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.64e-06	0.00166	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.61e-06	0.00164	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PGK1—kidney cancer	2.61e-06	0.00164	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC5A3—kidney cancer	2.61e-06	0.00164	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.56e-06	0.00161	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LDHB—kidney cancer	2.56e-06	0.00161	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.51e-06	0.00158	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ITPR2—kidney cancer	2.48e-06	0.00156	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.47e-06	0.00155	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ACY1—kidney cancer	2.36e-06	0.00148	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.34e-06	0.00147	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.32e-06	0.00146	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RPL14—kidney cancer	2.31e-06	0.00145	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.28e-06	0.00144	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTT1—kidney cancer	2.26e-06	0.00142	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ACHE—kidney cancer	2.26e-06	0.00142	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.24e-06	0.00141	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CA9—kidney cancer	2.22e-06	0.00139	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ACY1—kidney cancer	2.2e-06	0.00139	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.17e-06	0.00136	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SCARB1—kidney cancer	2.14e-06	0.00134	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS1—kidney cancer	2.12e-06	0.00133	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ITPR2—kidney cancer	2.09e-06	0.00131	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PSMD7—kidney cancer	2.08e-06	0.00131	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PDHB—kidney cancer	2.01e-06	0.00126	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—BCHE—kidney cancer	1.97e-06	0.00124	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SLC5A5—kidney cancer	1.94e-06	0.00122	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.93e-06	0.00121	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.9e-06	0.00119	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CCBL1—kidney cancer	1.89e-06	0.00119	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CRABP1—kidney cancer	1.88e-06	0.00118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.88e-06	0.00118	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SLC2A1—kidney cancer	1.88e-06	0.00118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PDHB—kidney cancer	1.87e-06	0.00118	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.87e-06	0.00118	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—POMC—kidney cancer	1.87e-06	0.00117	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.82e-06	0.00115	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.79e-06	0.00113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CCBL1—kidney cancer	1.76e-06	0.00111	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PSMD7—kidney cancer	1.75e-06	0.0011	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ITPR2—kidney cancer	1.75e-06	0.0011	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.74e-06	0.0011	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.72e-06	0.00108	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.65e-06	0.00104	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPAT—kidney cancer	1.64e-06	0.00103	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GLIPR1—kidney cancer	1.64e-06	0.00103	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.63e-06	0.00102	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.61e-06	0.00102	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ACHE—kidney cancer	1.6e-06	0.001	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTT1—kidney cancer	1.6e-06	0.001	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.59e-06	0.001	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.59e-06	0.000999	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SLC2A1—kidney cancer	1.58e-06	0.000996	CbGpPWpGaD
Atazanavir—ABCC1—Disease—JUNB—kidney cancer	1.57e-06	0.000989	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTP1—kidney cancer	1.57e-06	0.000984	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPAT—kidney cancer	1.53e-06	0.000961	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.53e-06	0.000961	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APRT—kidney cancer	1.52e-06	0.000956	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—FH—kidney cancer	1.52e-06	0.000956	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.52e-06	0.000954	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SCARB1—kidney cancer	1.51e-06	0.000951	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.51e-06	0.000949	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.5e-06	0.000943	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS1—kidney cancer	1.5e-06	0.000941	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.49e-06	0.000939	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ABCB1—kidney cancer	1.48e-06	0.000932	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PSMD7—kidney cancer	1.47e-06	0.000923	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.47e-06	0.000922	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ACY1—kidney cancer	1.45e-06	0.000914	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTM1—kidney cancer	1.44e-06	0.000905	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPC3—kidney cancer	1.43e-06	0.000899	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APRT—kidney cancer	1.42e-06	0.000893	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—FH—kidney cancer	1.42e-06	0.000893	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.4e-06	0.000878	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—BCHE—kidney cancer	1.39e-06	0.000875	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CA2—kidney cancer	1.39e-06	0.000874	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.39e-06	0.000874	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.39e-06	0.000873	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC5A5—kidney cancer	1.37e-06	0.000864	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP1A1—kidney cancer	1.36e-06	0.000858	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALAD—kidney cancer	1.36e-06	0.000852	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.35e-06	0.000848	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPC3—kidney cancer	1.34e-06	0.00084	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC2A1—kidney cancer	1.33e-06	0.000835	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.33e-06	0.000833	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.32e-06	0.000832	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.32e-06	0.000832	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.31e-06	0.000825	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CA2—kidney cancer	1.3e-06	0.000817	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.29e-06	0.000813	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.29e-06	0.00081	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN2B—kidney cancer	1.28e-06	0.000805	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.28e-06	0.000804	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALAD—kidney cancer	1.27e-06	0.000796	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.27e-06	0.000796	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PGK1—kidney cancer	1.24e-06	0.000779	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC5A3—kidney cancer	1.24e-06	0.000779	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PDHB—kidney cancer	1.24e-06	0.000777	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.24e-06	0.000777	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—POMC—kidney cancer	1.23e-06	0.000775	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LDHB—kidney cancer	1.22e-06	0.000764	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.21e-06	0.000759	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CCBL1—kidney cancer	1.16e-06	0.000731	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PGK1—kidney cancer	1.16e-06	0.000728	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.16e-06	0.000728	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.16e-06	0.000727	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LDHB—kidney cancer	1.14e-06	0.000714	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.12e-06	0.000706	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.12e-06	0.000705	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTP1—kidney cancer	1.11e-06	0.000696	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.09e-06	0.000687	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.06e-06	0.000669	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CA9—kidney cancer	1.05e-06	0.000663	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—kidney cancer	1.05e-06	0.000659	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.04e-06	0.000654	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIF1A—kidney cancer	1.02e-06	0.000644	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TSC2—kidney cancer	1.02e-06	0.000642	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—kidney cancer	1.02e-06	0.00064	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—POMC—kidney cancer	1.02e-06	0.000639	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.01e-06	0.000634	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPAT—kidney cancer	1.01e-06	0.000634	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CA9—kidney cancer	9.85e-07	0.000619	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	9.82e-07	0.000618	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP1A1—kidney cancer	9.64e-07	0.000606	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.62e-07	0.000605	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APRT—kidney cancer	9.37e-07	0.000589	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FH—kidney cancer	9.37e-07	0.000589	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.03e-07	0.000568	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KIT—kidney cancer	9.02e-07	0.000567	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APC—kidney cancer	9.02e-07	0.000567	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CRABP1—kidney cancer	8.96e-07	0.000563	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPC3—kidney cancer	8.81e-07	0.000554	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.73e-07	0.000549	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA2—kidney cancer	8.57e-07	0.000539	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—kidney cancer	8.48e-07	0.000533	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CRABP1—kidney cancer	8.37e-07	0.000526	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALAD—kidney cancer	8.35e-07	0.000525	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ITPR2—kidney cancer	8.33e-07	0.000524	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.15e-07	0.000512	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—kidney cancer	8.11e-07	0.00051	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.97e-07	0.000501	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.92e-07	0.000498	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ITPR2—kidney cancer	7.78e-07	0.000489	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PGK1—kidney cancer	7.64e-07	0.00048	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.64e-07	0.00048	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ACHE—kidney cancer	7.6e-07	0.000478	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—kidney cancer	7.6e-07	0.000478	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LDHB—kidney cancer	7.49e-07	0.000471	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SCARB1—kidney cancer	7.19e-07	0.000452	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—POMC—kidney cancer	7.19e-07	0.000452	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.17e-07	0.000451	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS1—kidney cancer	7.12e-07	0.000448	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—kidney cancer	7.1e-07	0.000446	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ACHE—kidney cancer	7.1e-07	0.000446	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RAF1—kidney cancer	7.08e-07	0.000445	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTEN—kidney cancer	7.07e-07	0.000445	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB2—kidney cancer	7e-07	0.00044	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSMD7—kidney cancer	6.98e-07	0.000439	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTOR—kidney cancer	6.91e-07	0.000435	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD4—kidney cancer	6.9e-07	0.000434	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—kidney cancer	6.85e-07	0.000431	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SCARB1—kidney cancer	6.72e-07	0.000422	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS1—kidney cancer	6.65e-07	0.000418	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BCHE—kidney cancer	6.62e-07	0.000416	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC5A5—kidney cancer	6.54e-07	0.000411	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSMD7—kidney cancer	6.52e-07	0.00041	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA9—kidney cancer	6.49e-07	0.000408	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1B—kidney cancer	6.49e-07	0.000408	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A1—kidney cancer	6.31e-07	0.000397	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BCHE—kidney cancer	6.18e-07	0.000389	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CTNNB1—kidney cancer	6.13e-07	0.000385	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.11e-07	0.000384	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.02e-07	0.000379	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTEN—kidney cancer	5.97e-07	0.000375	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.9e-07	0.000371	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—kidney cancer	5.73e-07	0.000361	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.72e-07	0.00036	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CRABP1—kidney cancer	5.52e-07	0.000347	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—kidney cancer	5.27e-07	0.000331	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ITPR2—kidney cancer	5.13e-07	0.000323	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK3—kidney cancer	5.1e-07	0.000321	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTEN—kidney cancer	5e-07	0.000314	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.99e-07	0.000314	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—kidney cancer	4.99e-07	0.000314	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—kidney cancer	4.96e-07	0.000312	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—kidney cancer	4.92e-07	0.000309	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK1—kidney cancer	4.85e-07	0.000305	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—kidney cancer	4.84e-07	0.000304	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ACHE—kidney cancer	4.68e-07	0.000294	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—kidney cancer	4.68e-07	0.000294	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—kidney cancer	4.66e-07	0.000293	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1A1—kidney cancer	4.59e-07	0.000288	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—kidney cancer	4.59e-07	0.000288	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—kidney cancer	4.52e-07	0.000284	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SCARB1—kidney cancer	4.43e-07	0.000279	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS1—kidney cancer	4.39e-07	0.000276	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSMD7—kidney cancer	4.3e-07	0.00027	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.29e-07	0.000269	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—kidney cancer	4.21e-07	0.000265	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BCHE—kidney cancer	4.08e-07	0.000256	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.03e-07	0.000253	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.89e-07	0.000245	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—kidney cancer	3.53e-07	0.000222	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.52e-07	0.000221	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—POMC—kidney cancer	3.42e-07	0.000215	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—kidney cancer	3.24e-07	0.000204	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—POMC—kidney cancer	3.2e-07	0.000201	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—kidney cancer	3.07e-07	0.000193	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—kidney cancer	2.98e-07	0.000187	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.83e-07	0.000178	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—kidney cancer	2.73e-07	0.000172	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—kidney cancer	2.55e-07	0.00016	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTEN—kidney cancer	2.38e-07	0.00015	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTEN—kidney cancer	2.22e-07	0.00014	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—POMC—kidney cancer	2.11e-07	0.000133	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—kidney cancer	1.68e-07	0.000106	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—kidney cancer	1.68e-07	0.000106	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.57e-07	9.86e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTEN—kidney cancer	1.47e-07	9.22e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.03e-07	6.5e-05	CbGpPWpGaD
